Martina Garnero

Triple-M syndrome after immune checkpoint inhibitors: a systematic review of cases-early recognition is critical to survival.

Journal: Frontiers in neurology

Published: April 21, 2026

High-resolution ultrasound of peripheral neuropathies in rheumatological patients: An overview of clinical applications and imaging findings.

Journal: Frontiers in medicine

Published: July 01, 2022

A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection.

Journal: Journal of neuroimmunology

Published: March 07, 2021

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.

Journal: Journal of the neurological sciences

Published: May 26, 2020

Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.

Journal: Journal of the neurological sciences

Published: December 31, 2019

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.

Journal: Journal of neuroimmunology

Published: June 13, 2019

Diagnostics of anti-MAG antibody polyneuropathy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: October 15, 2017

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Journal: Journal of clinical neurology (Seoul, Korea)

Published: May 23, 2017

Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.

Journal: Scientific reports

Published: March 29, 2017

IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 27, 2017

Dysimmune mononeuropathies: A diagnosis not to be missed.

Journal: Muscle & nerve

Published: August 28, 2015

Guillain-Barré syndrome following chickenpox: a case series.

Journal: The International journal of neuroscience

Published: May 23, 2015

Triple-M syndrome after immune checkpoint inhibitors: a systematic review of cases-early recognition is critical to survival.

Triple-M syndrome after immune checkpoint inhibitors: a systematic review of cases-early recognition is critical to survival.

High-resolution ultrasound of peripheral neuropathies in rheumatological patients: An overview of clinical applications and imaging findings.

High-resolution ultrasound of peripheral neuropathies in rheumatological patients: An overview of clinical applications and imaging findings.

A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection.

A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection.

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.

Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.

Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy.

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.

Diagnostics of anti-MAG antibody polyneuropathy.

Diagnostics of anti-MAG antibody polyneuropathy.

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis.

Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.

Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies.

IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.

IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.

Dysimmune mononeuropathies: A diagnosis not to be missed.

Dysimmune mononeuropathies: A diagnosis not to be missed.

Guillain-Barré syndrome following chickenpox: a case series.

Guillain-Barré syndrome following chickenpox: a case series.

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.

Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.